At a Glance
ARCH Venture Partners is a venture capital firm based in Chicago, IL founded in 1986. ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences The firm focuses on Seed, Series A investments across sectors including Biotech, Digital Health. The firm manages $3.7B in assets under management. Notable portfolio companies include Moderna, 10x Genomics, Juno Therapeutics, Lyft, UiPath and Unity Biotechnology. Invests at concept stage, co-founding breakthrough life sciences and technology platforms with transformative potential.
“Invests at concept stage, co-founding breakthrough life sciences and technology platforms with transformative potential.”
Clinton Bybee
Co-Founder and Managing Director Emeritus, ARCH Venture Partners
Kristina Burow
Managing Director, ARCH Venture Partners
Mark McDonnell
Managing Director, ARCH Venture Partners
Paul Berns
Managing Director, ARCH Venture Partners
Robert Nelsen
Co-Founder and Managing Director, ARCH Venture Partners
Steve Gillis
Managing Director, ARCH Venture Partners
ARCH Venture Partners primarily invests at the Seed, Series A stages. This means they focus on companies that are building their initial product and finding product-market fit.
ARCH Venture Partners is headquartered in Chicago, IL. Many of their portfolio companies are also based in this region, though they invest across geographies.
ARCH Venture Partners focuses on investments in Biotech, Digital Health. Their portfolio reflects deep expertise and networks within these sectors.
ARCH Venture Partners's typical investment check size ranges from $500K to $5M. Actual amounts may vary based on the stage, sector, and specific opportunity.
ARCH Venture Partners manages approximately $3.7B in assets under management (AUM) across their funds.
